Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
Carmelo Quarta and Daniela Cota Share last authorship Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
PMID 20985610
Most vomiting episodes cluster in the first 8 to 20 weeks, corresponding to the 0.25 mg through 1.7 mg escalation steps
All day, every day, your immune system fights off infection, removes damaged cells from your body, balances inflammation, and works tirelessly to keep you healthy
Your current dose may be adjusted, or your doctor may make adjustments to your dosing schedule
